Cypher Sirolimus-Eluting Stent

DEVICE4 trials

Sponsors

Cordis US Corp.

Conditions

Coronary Artery Disease

Phase 3

Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)

CompletedNCT00232765

Cordis US Corp.Coronary Artery Disease

Start: 2001-02-28End: 2008-11-30Updated: 2009-09-16

Phase 4

The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus

CompletedNCT00235092

Cordis US Corp.Coronary Artery Disease

Start: 2003-08-31End: 2006-03-31Target: 1335Updated: 2007-04-27

A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions

CompletedNCT00495898

Cordis US Corp.Coronary Artery Disease

Start: 2002-11-30End: 2009-11-30Updated: 2009-12-03

Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial

CompletedNCT00497172

Cordis US Corp.Coronary Artery Disease

Start: 2004-01-31End: 2009-04-30Updated: 2010-02-04

Related Papers

5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.

2009-09-01100 citations

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.

2007-02-12472 citations

Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.

2006-02-01331 citations